Delayed resolution of inflammatory response compared with clinical recovery in patients with acute exacerbations of chronic obstructive pulmonary disease

被引:11
作者
Mohan, Anant [1 ]
Prasad, Dharmendra [2 ]
Sharma, Alpana [3 ]
Arora, Sneh [1 ]
Guleria, Randeep [1 ]
Sharma, Surendra K. [2 ]
Pandey, Ravinder M. [4 ]
机构
[1] All India Inst Med Sci, Dept Pulm Med & Sleep Disorders, New Delhi 110029, India
[2] All India Inst Med Sci, Dept Med, New Delhi 110029, India
[3] All India Inst Med Sci, Dept Biochem, New Delhi 110029, India
[4] All India Inst Med Sci, Dept Biostat, New Delhi 110029, India
关键词
acute exacerbation; acute-phase reactant; chronic obstructive pulmonary disease; cytokine; inflammation; C-REACTIVE PROTEIN; SYSTEMIC INFLAMMATION; COPD EXACERBATIONS; ANTIBIOTIC-THERAPY; BIOMARKERS; MARKERS; PROCALCITONIN; VALIDATION; MORTALITY; SPUTUM;
D O I
10.1111/j.1440-1843.2012.02216.x
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background and objective: The temporal profile of inflammatory markers during acute exacerbations of chronic obstructive pulmonary disease (AECOPD) and their relationship to clinical response are not well characterized. The aim was to assess the changes in levels of inflammatory markers in AECOPD and correlate these with clinical and laboratory indices of recovery. Methods: Serum levels of C-reactive protein (CRP), interleukin (IL)-6 and fibrinogen were measured in patients with AECOPD within 24 h of hospitalization and pre-discharge (stable state). Results: Ninety-seven patients were evaluated (79 males; mean (SD) age, 61.4 (10.3) years). Eighty eight (90.7%) were current or former smokers, with a median consumption of 15 (075) packs/year. The median duration of COPD was 8 (225) years. Forty-six patients (56.9%) required mechanical ventilation for a median of 5 days (134) while in hospital. The median duration of hospital stay was 13 days (177). At reassessment before planned discharge, the levels of dyspnoea, leucocyte counts, erythrocyte sedimentation rate, creatinine, partial pressure of oxygen, and albumin normalized. The levels of CRP, IL-6 and fibrinogen reduced significantly but did not reach the normal range. Changes in IL-6 and fibrinogen levels correlated significantly with the acute physiologic assessment and chronic health evaluation II score, smoking history, blood pressure and leucocyte counts. Baseline IL-6 and fibrinogen levels significantly predicted a prolonged duration of mechanical ventilation. Conclusions: During AECOPD, the inflammatory response lags behind clinical and biochemical improvement. Fibrinogen and IL-6 are potentially useful markers for monitoring clinical response following an acute episode.
引用
收藏
页码:1080 / 1085
页数:6
相关论文
共 28 条
[1]   ANTIBIOTIC-THERAPY IN EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].
ANTHONISEN, NR ;
MANFREDA, J ;
WARREN, CPW ;
HERSHFIELD, ES ;
HARDING, GKM ;
NELSON, NA .
ANNALS OF INTERNAL MEDICINE, 1987, 106 (02) :196-204
[2]   Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations [J].
Bhowmik, A ;
Seemungal, TAR ;
Sapsford, RJ ;
Wedzicha, JA .
THORAX, 2000, 55 (02) :114-120
[3]   Raised CRP levels mark metabolic and functional impairment in advanced COPD [J].
Broekhuizen, R ;
Wouters, EFM ;
Creutzberg, EC ;
Schols, AMWJ .
THORAX, 2006, 61 (01) :17-22
[4]   C-reactive protein and body mass index predict outcome in end-stage respiratory failure [J].
Cano, NJM ;
Pichard, C ;
Roth, H ;
Court-Fortuné, I ;
Cynober, L ;
Gérard-Boncompain, M ;
Cuvelier, A ;
Laaban, JP ;
Melchior, JC ;
Raphaël, JC ;
Pison, CM .
CHEST, 2004, 126 (02) :540-546
[5]   Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper [J].
Celli, BR ;
MacNee, W ;
Agusti, A ;
Anzueto, A ;
Berg, B ;
Buist, AS ;
Calverley, PMA ;
Chavannes, N ;
Dillard, T ;
Fahy, B ;
Fein, A ;
Heffner, J ;
Lareau, S ;
Meek, P ;
Martinez, F ;
McNicholas, W ;
Muris, J ;
Austegard, E ;
Pauwels, R ;
Rennard, S ;
Rossi, A ;
Siafakas, N ;
Tiep, B ;
Vestbo, J ;
Wouters, E ;
ZuWallack, R .
EUROPEAN RESPIRATORY JOURNAL, 2004, 23 (06) :932-946
[6]   VALIDATION OF A COMBINED COMORBIDITY INDEX [J].
CHARLSON, M ;
SZATROWSKI, TP ;
PETERSON, J ;
GOLD, J .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1994, 47 (11) :1245-1251
[7]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[8]   Procalcitonin vs C-Reactive Protein as Predictive Markers of Response to Antibiotic Therapy in Acute Exacerbations of COPD [J].
Daniels, Johannes M. A. ;
Schoorl, Marianne ;
Snijders, Dominic ;
Knol, Dirk L. ;
Lutter, Rene ;
Jansen, Henk M. ;
Boersma, Wim G. .
CHEST, 2010, 138 (05) :1108-1115
[9]   Value of C-reactive protein measurements in exacerbations of chronic obstructive pulmonary disease [J].
Dev, D ;
Wallace, E ;
Sankaran, R ;
Cunniffe, J ;
Govan, JRW ;
Wathen, CG ;
Emmanuel, FXS .
RESPIRATORY MEDICINE, 1998, 92 (04) :664-667
[10]   TUMOR-NECROSIS-FACTOR-ALPHA LEVELS AND WEIGHT-LOSS IN CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].
DIFRANCIA, M ;
BARBIER, D ;
MEGE, JL ;
OREHEK, J .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 150 (05) :1453-1455